Ascentage Pharma Group International
AAPG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023311
No open-market purchases or sales by Ascentage Pharma Group International insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $263.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Ascentage Pharma Group International changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 81.8K | 94.1K | +12.3K (+15.0%) |
| Value | $3.22M | $3.69M | +$465.8K (+14.5%) |
New holders (6)
Institutions that held Ascentage Pharma Group International at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 9,652 | $383.1K | 0.00% |
| Abc Arbitrage SA | 5,230 | $204.2K | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 2,463 | $96.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 829 | $32.4K | 0.00% |
| Advisor Group Holdings, Inc. | 220 | $8.48K | 0.00% |
| Bank of America Corp | 180 | $7.03K | 0.00% |
Sold out (4)
Institutions that held Ascentage Pharma Group International at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| HSBC Holdings PLC | 9,933 | $391.3K |
| Chevy Chase Trust Holdings, Inc. | 5,753 | $226.5K |
| JPMorgan Chase & Co | 211 | $8.31K |
| Royal Bank of Canada | 6 | $0 |